Skip to main content
. 2022 Dec 20:1–7. doi: 10.1159/000528736

Table 3.

Anti-FXa level

Therapeutic dose (N = 19) Intermediate dose (N = 23) p value
Anti-FXa activity
 Anti-FXa within the expected range 0.2–0.5 U/mL 8 (42.1) 12 (52.2) 0.520
Out of expected range
 Anti-FXa above the expected range 9 (47.4) 3 (13) 0.015
 Anti-FXa below the expected range 2 (10.5) 8 (34.8) 0.069

Values are shown as frequency (percentage).